Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 10
(12)
◽
pp. 6677-6694
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):